AInvest Newsletter
Daily stocks & crypto headlines, free to your inbox
C3.ai Investors File Lawsuit Over Misleading Statements, CEO Health Concerns
ByAinvest
Thursday, Sep 18, 2025 8:57 am ET1min read
The Gross Law Firm is investigating a potential securities fraud class action against C3.ai, Inc. (NYSE: AI) on behalf of shareholders who purchased shares between February 26, 2025 and August 8, 2025. The complaint alleges that defendants made false and misleading statements about the company's growth, particularly regarding the impact of the CEO's health on closing deals and management's effectiveness. Shareholders who purchased shares during this period are encouraged to contact the firm regarding possible lead plaintiff appointment.
The Gross Law Firm has issued a notice to shareholders of C3.ai, Inc. (NYSE: AI) regarding a potential securities fraud class action lawsuit. The class action, filed on behalf of investors who purchased shares between February 26, 2025, and August 8, 2025, alleges that the company made false and misleading statements about its growth prospects, particularly concerning the impact of the CEO's health on closing deals and the effectiveness of management [1].The complaint specifies that C3.ai provided overwhelmingly positive statements to investors while concealing material adverse facts about the company's true state. Notably, it is alleged that the company failed to disclose the significant impact of the CEO's health on the company's ability to close deals and that management was unable to effectively minimize this impact. On August 8, 2025, C3.ai announced disappointing preliminary financial results for the first quarter of fiscal 2026 and reduced its revenue guidance for the full fiscal year 2026, citing "the reorganization with new leadership" and the health ailments of its CEO. Following this news, the price of C3.ai's common stock declined dramatically, falling from $22.13 per share to $16.47 per share on August 11, 2025, a decline of about 25.58% in just a single day [2].
Shareholders who purchased shares during the specified class period are encouraged to contact the Gross Law Firm before October 21, 2025, to discuss their rights and potential lead plaintiff appointment. The firm is committed to protecting the rights of investors who have suffered as a result of deceit, fraud, and illegal business practices [1].
Investors should note that the deadline to seek to be a lead plaintiff is October 21, 2025. There is no cost or obligation to participate in this case. Once registered, shareholders will be enrolled in a portfolio monitoring software to receive status updates throughout the lifecycle of the case [2].
Ainvest News articles are AI-generated using advanced large language model (LLM) technology designed to analyze and synthesize publicly available data and news. While AI tools assist in producing initial drafts and insights, all AI generated content published on Ainvest is subject to comprehensive human editorial review before publication. A designated human editor reviews, verifies, and approves each article for factual accuracy, coherence, and compliance with AInvest Fintech Inc’s editorial and disclosure standards.
Despite these review procedures, the information provided may still contain inaccuracies, incomplete data, or time sensitive references due to the inherent limitations of AI generated analysis and evolving changes. The material is provided strictly for informational and educational purposes and does not constitute personalized investment, legal, or financial advice. Readers should independently verify all facts, figures, and statements before making any decision based on this content.
AInvest Fintech Inc. its affiliates, and partners accept no liability or responsibility for any direct or consequential losses arising from reliance on this content. All articles and analyses are subject to revision, update, or removal without prior notice to maintain accuracy and integrity in our publications.
Comments
No comments yet